|

Impact of Extracorporeal Life Support on Cardiogenic Shock Patients

ByThe Short Paper

Extracorporeal Life Support in Infarct-Related Cardiogenic Shock

A multicenter trial examined the use of extracorporeal life support (ECLS) in patients with acute myocardial infarction complicated by cardiogenic shock. The study found that ECLS therapy did not significantly reduce the risk of death at 30 days compared to those who received medical therapy alone. However, ECLS was associated with higher rates of bleeding and peripheral vascular complications.

https://www.nejm.org/doi/full/10.1056/NEJMoa2307227

Similar Posts

|

Safeguarding Biodiversity: The Role and Challenges of Protected Areas

ByThe Short Paper

Protected areas slow declines unevenly across the tetrapod tree of life Protected areas (PAs) play a crucial role in slowing down the loss of terrestrial biodiversity. A study analyzing data from around the world found that vertebrate populations decline much slower within protected areas compared to similar sites without protection. The effectiveness of PAs varied…

|

Study on Dexamethasone for Tuberculous Meningitis in HIV Patients

ByThe Short Paper

This was a double-blind, randomized trial involving HIV-positive adults with tuberculous meningitis in Vietnam and Indonesia examined the effectiveness of dexamethasone, an anti-inflammatory drug, as an adjunct treatment. Participants received either dexamethasone or a placebo in addition to antituberculosis therapy. The study found that dexamethasone did not significantly improve survival rates or secondary outcomes, such…

Single-Dose Psilocybin Treatment for Major Depressive Disorder

ByThe Short Paper

One-time psilocybin treatment for depression A study investigated the effectiveness and safety of psilocybin, a compound found in certain mushrooms, for treating major depressive disorder. In a controlled trial with 104 adults, a 25-mg dose of psilocybin, when combined with psychological support, resulted in a significant and enduring improvement in depressive symptoms compared to a…

|

Uncovering the Biology of Long COVID

ByThe Short Paper

Distinguishing features of Long COVID identified through immune profiling Some people develop post-acute infection syndromes (PAIS) after recovering from viral diseases like COVID-19, resulting in symptoms known as “Long COVID” (LC), including fatigue and cognitive issues. A study involving 273 individuals, some with LC and some without, used immune profiling and machine learning to identify…

|

Gut Fungi and Immune Activation in Severe COVID-19: New Insights

ByThe Short Paper

Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19 This study delves into the role of gastrointestinal fungal dysbiosis in severe COVID-19 cases and its impact on the host’s immune system. Elevated levels of Candida albicans antibodies were found in severe COVID-19 patients with gut Candida overgrowth, mycobiota imbalance, and…

|

CPAP Adherence Reduces Cardiovascular Risks in Sleep Apnea Patients

ByThe Short Paper

Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis A study examined the impact of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) on the risk of cardiovascular events. The research found that good adherence to CPAP significantly reduced the recurrence risk of major adverse cardiac and cerebrovascular…